Web Research
Web Research — What the Internet Knows
The Bottom Line from the Web
The web confirms what the filings imply but won't say outright: Supreme is a founder-controlled, AIM-listed roll-up whose vape windfall is being deliberately diluted into soft drinks, tea, and weight-management brands before regulation re-prices the cash cow. The single most important off-filing data point is the December 2025 founder share placement — Sandy Chadha sold 2.0m shares (~£3.1m) yet still controls 56.31% of the equity, signalling personal liquidity, not loss of conviction. The external valuation context is equally striking: independent screens peg SUP at roughly 0.8x EV/Revenue and 5.1x EV/EBITDA on LTM (multiples.vc, May 2026) versus a 12-month consensus price target of 229.5p — well above the ~150p where the shares are trading.
What Matters Most
Founder share placement (Dec 2025) — £3.1m sold, 56.31% retained. Sandy Chadha placed 2,000,000 shares to institutional buyers at ~156p in early December 2025, his second secondary in fourteen months (the prior 1.6m at 160p in Oct 2024 was characterised the same way). Sources: themarketsdaily.com (5 Dec 2025), dailypolitical.com (2 Dec 2025), tipranks.com (14 Oct 2024). Two prints in fifteen months is a pattern worth watching, but the residual 56.31% control means interests remain heavily aligned.
Vape ban looks more priced-in than feared. The 1 June 2025 disposable ban was already telegraphed when management said in mid-2024 that the rechargeable pod kit "looks the same and delivers the same flavour, costs the same as the disposable" — and FY26 H1 vaping revenue grew 13% per management commentary. The market discount appears tied more to the pending excise levy (Oct 2026) than to the ban itself. Source: tridentopportunities.substack.com (FY24 update, Jul 2024); H1 FY26 RNS via investors.supreme.co.uk.
Acquisition cadence has stepped up materially. Within 14 months Supreme has closed Clearly Drinks (Aug 2024, ~£15m), Typhoo Tea from administration (Dec 2024, £10.2m / $12.94m per Reuters), 1001 carpet care (Sep 2025), and SlimFast UK & Europe (Oct 2025, £20.1m per Investing.com). The Typhoo deal generated a ~£2.9m bargain-purchase gain because it was bought from administration — distinct from goodwill but a reminder these are distressed-asset deals that need integration proof.
Concentrated ownership = thin public float. Yahoo/SimplyWallSt (Sep 2024 and Feb 2025) put insider ownership at 33–34% with Chadha personally holding 33% and Supreme 88 Ltd a further 24% — the top two shareholders control 56–58% of shares. Moneta Asset Management is the largest non-insider at ~7%. Hedge-fund footprint is "not meaningful". Combined with AIM listing, this explains the persistent valuation discount to peers and limits realistic ADV.
Consensus price target sits well above the tape. Fintel reports a one-year average price target of 229.5p (range 227.25–236.25p) versus a current ~150p print — implying ~50% upside if consensus is right, but coverage is thin (Simply Wall St explicitly notes the stock is "probably not widely covered"). Source: fintel.io.
FY26 Q2 result missed consensus by a hair. TipRanks recorded the 25 Nov 2025 H1 earnings release at 0.091p EPS vs 0.095p consensus (–0.004p miss), even as half-year revenue grew to £118.09m (+29.8% YoY). The miss is small but matters for a stock priced for accelerating diversification. Source: tipranks.com, stockanalysis.com.
Dividend yield ~3.5%, quarterly cadence preserved through M&A. DividendMax shows the most recent dividend of 1.6p paid four months ago, with the next ex-div forecast in four months — i.e. capital return continues despite the heavy acquisition spend. Source: dividendmax.com.
Gross margin step-up to ~31% appears structural. Multiples.vc (May 2026) shows LTM gross margin of 31% and EBITDA margin of 15% (vs prior FY of 18%), consistent with the Clearly/Typhoo mix-shift narrative. The EBITDA margin compression LTM-vs-FY needs watching: it could be integration cost or it could be the disposable-ban transition.
Long-running independent bull case (Trident Opportunities Substack, Apr 2024 + Jul 2024 update). Independent investor write-up framed Supreme as a vertically integrated FMCG distributor at 3.5x EV/EBITDA, with Vaping then 49% of revenue and Branded Distribution (ElfBar/Lost Mary) as the FY24 growth engine. Stock has roughly doubled since the original 120p pitch. The author argued the disposable ban would be "more of a non-event" — a thesis the FY26 H1 numbers tentatively support.
Recent News Timeline
What the Specialists Asked
The specialists submitted 30 targeted questions for web verification. With Phase-2 web fetch skipped on this ultralight run, answers below are best-effort synthesis from the four phase-1 research files (61 Brave queries, 40 page fetches).
Insider Spotlight
Web research is consistent across SimplyWallSt (Sep 2024, Feb 2025), Companies House and Yahoo Finance: Sandy (Sandeep Singh) Chadha is CEO since Dec 2017, Person-with-Significant-Control, and the dominant gravitational force on the share register.
SimplyWallSt: "Sandy's compensation has been consistent with company performance over the past year."
The CFO purchase in May 2023 (21,000 shares at ~130p) is small but directionally positive. The two CEO placements bracket the most aggressive M&A burst in the company's history — consistent with personal liquidity raising rather than loss of conviction, given residual 56.31% control.
Industry Context
The web reveals three structural forces shaping the FMCG distribution category Supreme operates in:
- UK vaping regulation in transition. Disposable ban (1 Jun 2025) is in effect; the 2026 vape excise duty and the structural shift to refillable pods are the next legislative dominos. Independent commentary (Trident, Apr 2024) and management's own pod-parity argument frame the ban as a re-platforming event rather than a demand event.
- Distressed-asset opportunity in UK consumer brands. Typhoo Tea (administration), 1001, and SlimFast all came at non-strategic prices, reflecting the broader stress in mid-tier UK consumer brands. Supreme's vertically integrated distribution model (substack thesis) makes it a logical buyer of orphan brands needing a route-to-shelf.
- AIM small-cap discount persists. External screens consistently price SUP at ~5x EV/EBITDA versus 8–12x for AIM consumer comps with deeper liquidity. The web debate frames this as a structural AIM/free-float discount layered on a vape-overhang discount — both of which compress over time if the diversification thesis plays out.
Phase-2 web fetch was skipped on this ultralight run, so several specialist questions remain "Limited evidence." Six findings depend on UK regulatory filings (HMRC consultations, FRC ethical standard, AIM AGM voting disclosures) that the four phase-1 research files do not surface. Those should be treated as known-unknowns rather than green-lit absences.